Yahoo
LSE - Delayed Quote GBp

Ondine Biomedical Inc. (OBI.L)

9.75 0.00 (0.00%)
At close: October 30 at 4:35:20 PM GMT
View in AlphaSpace Currency in CAD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,878
2,646
2,049
1,203
638
Cost of Revenue
1,112
1,034
728
500
351
Gross Profit
1,766
1,612
1,321
703
287
Operating Expense
35,130
31,579
20,765
15,508
19,050
Operating Income
-33,364
-29,967
-19,444
-14,805
-18,763
Net Non Operating Interest Income Expense
208
345
-15
204
161
Pretax Income
-33,117
-29,517
-19,098
-14,412
-19,372
Net Income Common Stockholders
-33,117
-29,517
-19,098
-14,412
-19,372
Diluted NI Available to Com Stockholders
-33,117
-29,517
-19,098
-14,412
-19,372
Basic EPS
-0.06
--
-0.07
-0.07
-0.10
Diluted EPS
-0.06
--
-0.07
-0.07
-0.10
Basic Average Shares
512,608.94
--
274,600.78
197,111.57
194,588.25
Diluted Average Shares
512,608.94
--
274,600.78
197,111.57
194,588.25
Total Operating Income as Reported
-33,364
-29,967
-19,444
-14,805
-18,763
Rent Expense Supplemental
--
--
253
189
132
Total Expenses
36,242
32,613
21,493
16,008
19,401
Net Income from Continuing & Discontinued Operation
-33,117
-29,517
-19,098
-14,412
-19,372
Normalized Income
-33,165
-29,581
-19,425
-14,749
-17,960
Interest Income
236
366
32
242
191
Interest Expense
28
21
47
38
30
Net Interest Income
208
345
-15
204
161
EBIT
-33,089
-29,496
-19,051
-14,374
-19,342
EBITDA
-32,522
-28,906
-18,486
-13,787
-18,849
Reconciled Cost of Revenue
1,112
1,034
728
500
351
Reconciled Depreciation
567
590
565
587
493
Net Income from Continuing Operation Net Minority Interest
-33,117
-29,517
-19,098
-14,412
-19,372
Total Unusual Items Excluding Goodwill
48
64
327
337
-1,412
Total Unusual Items
48
64
327
337
-1,412
Normalized EBITDA
-32,570
-28,970
-18,813
-14,124
-17,437
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/6/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: